SCHEMBL6398786

SCHEMBL6398786

Cc1cccc(C#Cc2ccc3c(c2)NCCO3)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
HSD17B10 Q99714 1/20 0.49
GRM5 P41594 7/20 0.48
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
PKM P14618 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
CYP2C19 P33261 1/20 0.47
THPO P40225 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6798236 0.82 GRM5 (0.55) ALDH1A1GRM5NPC1RAB9ASMN1; SMN2
SCHEMBL6797207 0.80 GRM5 (0.52) ALDH1A1GRM5NPC1RAB9ASMN1; SMN2
SCHEMBL6429370 0.79 NR3C2 (0.53) ALDH1A1GRM5NPC1RAB9ASMN1; SMN2
SCHEMBL6395028 0.76 GRM5 (0.50) ALDH1A1GRM5NPC1RAB9ASMN1; SMN2
SCHEMBL6393511 0.72 GRM5 (0.44) ALDH1A1GRM5NPC1RAB9ASMN1; SMN2
SCHEMBL7266673 0.72 GRM5 (0.49) ALDH1A1GRM5NPC1RAB9ASMN1; SMN2
SCHEMBL6392419 0.71 RIPK1 (0.41) ALDH1A1GRM5NPC1RAB9ASMN1; SMN2
SCHEMBL23076327 0.71 RIPK1 (0.48) ALDH1A1GRM5NPC1RAB9ASMN1; SMN2
SCHEMBL2599678 0.71 ALDH1A1 (0.59) ALDH1A1GAAMAPTHSD17B10GRM5
SCHEMBL30514060 0.71 ALDH1A1 (0.59) ALDH1A1GAAMAPTHSD17B10GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050165011-A1 Benzoxazine and benzoxazinone substituted triazoles GELLIBERT FRANCOISE J (FR) 2005-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050165011-A1 Benzoxazine and benzoxazinone substituted triazoles ACVR1, TGFBR1, SMAD3 ALDH1A1 3541/4885GAA 1537/4885MAPT 1751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.